Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Meiragtx Holdings Plc (MGTX)

Meiragtx Holdings Plc (MGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Meiragtx Holdings Plc 450 East 29th Street 14th Floor NEW YORK NY 10016 USA

www.meiragtx.com P: 646-860-7985

Description:

MeiraGTx Holdings plc focuses on operating as a holding company for MeiraGTx Limited which operates as a clinical stage gene therapy company. It develops novel gene therapy treatments for inherited and acquired disorders. The company's product pipeline consists of AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, AAV-AQP1 and AAV-UPF1 which are in clinical stage. MeiraGTx Holdings plc is based in New York.

Key Statistics

Overview:

Market Capitalization, $K 365,264
Enterprise Value, $K 307,814
Shares Outstanding, K 64,307
Annual Sales, $ 14,020 K
Annual Net Income, $ -84,030 K
Last Quarter Sales, $ 700 K
Last Quarter Net Income, $ -20,440 K
EBIT, $ -152,070 K
EBITDA, $ -137,080 K
60-Month Beta 1.31
% of Insider Shareholders 9.70%
% of Institutional Shareholders 67.48%
Float, K 58,069
% Float 90.30%
Short Volume Ratio 0.54

Growth:

1-Year Return -25.84%
3-Year Return -57.89%
5-Year Return -76.67%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 48.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.77 on 05/09/24
Latest Earnings Date N/A
Earnings Per Share ttm -2.51
EPS Growth vs. Prev Qtr -63.83%
EPS Growth vs. Prev Year -24.19%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MGTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -122.82%
Return-on-Assets % -48.11%
Profit Margin % -599.36%
Debt/Equity 0.59
Price/Sales 25.37
Price/Cash Flow N/A
Price/Book 2.76
Book Value/Share 1.89
Interest Coverage -5.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar